Explore more
AI in Drug Discovery: From Lab Hype to Clinical Reality in 2026
Join us to discover what has changed in AI-led drug development in the last year, which breakthroughs actually matter, and what to watch for in the year ahead.
From Point Solutions to Enterprise: How AI Is Reshaping Research & Decision Making
In this roundtable, Doug Garber (Pitch The PM), Chris Vitale (the alloy network), and Ben Collins (AlphaSense) will discuss how AI is actually being deployed on the ground today — what’s working, what isn’t, and where the biggest ROI is emerging.
Software Under Pressure: AI Uncertainty and the Path to Growth
Join this live Quarterly AI Update with AlphaSense and Morgan Stanley as they explore the core findings of Morgan Stanley’s recent report, “Software Gut Check – AI IS Software,” to help you navigate the road ahead for incumbent vendors and emerging disruptors.
Transform intelligence
into advantage
Develop bold strategies, seize opportunities, and lead with clarity and confidence.